Microsoft Stock Falls 2.7% on AI Spending Doubts, June 08

Microsoft MSFT stock fell 2.7% to $416.67 on June 08 after Wall Street divided on the company’s AI strategy. Barclays cut its price target to $545 from $600, citing valuation concerns despite AI tailwinds. Wells Fargo raised its target to $625, backing the Azure acceleration narrative. The tension between enterprise demand and rising capital spending defines the current debate. Meyka rates MSFT an A with a 12-month forecast of $524.66, suggesting limited downside from current levels.

Why Analysts Disagree on Microsoft’s AI Bet

Barclays and Wells Fargo both see Azure acceleration and AI tailwinds, but disagree on valuation. Barclays noted that Microsoft’s AI business reached $37 billion in annualized run rate and that Microsoft 365 and Azure are both guided to accelerate. However, Barclays trimmed its price target to $545 from $600, citing a more disciplined view on the multiple. Wells Fargo raised its target to $625, arguing that investments are clearly paying off based on Copilot seat additions and usage confidence. The 84% capital expenditure surge and 27x P/E multiple remain flashpoints in the debate.

Capital Spending Concerns Weigh on Stock

Microsoft’s massive infrastructure investments collide with concerns over return justification. The company’s CapEx surge and elevated valuation have sparked worry about software multiple compression in a vulnerable market. Barclays asserted that Microsoft’s spending commentary shows healthy expansion driven by ongoing AI capacity shortage. Wells Fargo counters that the company’s guidance for M365 and Azure acceleration, plus the $37 billion AI business run rate, justify the spending. Both firms kept Overweight ratings despite the price target divergence.

Meyka Rating and Technical Signals

Meyka rates Microsoft an A with a 12-month price target of $524.66, implying 26% upside from current levels. The stock trades at a 24.8x P/E ratio against a market cap of $3.10 trillion. Technical indicators show the RSI at 47.44, signaling neither overbought nor oversold conditions. The stock remains above its 50-day average of $406.33, though it has fallen 13.8% year-to-date. Analyst consensus stands at Moderate Buy with a price target of $561.20.

What This Means for Investors

Microsoft’s AI spending debate reflects broader market uncertainty about tech valuations. With Meyka rating MSFT an A and the 12-month target at $524.66, the data suggests the stock has room to recover from current weakness. Wells Fargo’s $625 target and Barclays’ $545 target bracket analyst views, with consensus at $561.20. The key question for investors is whether Azure’s acceleration and the $37 billion AI run rate justify the elevated capital spending and 27x P/E multiple.

Final Thoughts

Microsoft stock fell 2.7% as Wall Street split on AI spending returns. With Meyka rating MSFT an A and targeting $524.66 in 12 months, the data points to recovery potential if Azure acceleration materializes as expected.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.